AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · IEX Real-Time Price · USD
3.640
-0.140 (-3.70%)
At close: May 17, 2024, 4:00 PM
3.660
+0.020 (0.55%)
After-hours: May 17, 2024, 7:46 PM EDT
AbCellera Biologics Employees
AbCellera Biologics had 586 employees on December 31, 2023. The number of employees increased by 91 or 18.38% compared to the previous year.
Employees
586
Change (1Y)
91
Growth (1Y)
18.38%
Revenue / Employee
$61,072
Profits / Employee
-$250,679
Market Cap
1.07B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 586 | 91 | 18.38% |
Dec 31, 2022 | 495 | 109 | 28.24% |
Dec 31, 2021 | 386 | 180 | 87.38% |
Dec 31, 2020 | 206 | 99 | 92.52% |
Dec 31, 2019 | 107 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
ABCL News
- 10 days ago - AbCellera Reports Q1 2024 Business Results - Business Wire
- 17 days ago - AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies - Business Wire
- 5 weeks ago - AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 - Business Wire
- 6 weeks ago - AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 - Business Wire
- 2 months ago - AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 - Business Wire
- 2 months ago - AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions - Business Wire
- 2 months ago - AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 - Business Wire
- 3 months ago - AbCellera Announces Resignation of Board Member - Business Wire